📰 Spirovant Sciences News
Page 2 - Spirovant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Spirovant Sciences. Real-time updates on events, politics, business and more.
December 9, 2021
/PRNewswire/ -- The "Trikafta Patent, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.coms offering. Global Trikafta market...
December 9, 2021
/PRNewswire/ -- The "Trikafta Patent, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.coms offering. Global Trikafta market...
November 4, 2021
/PRNewswire/ -- Spirovant Sciences, a gene therapy company developing treatments and cures for inherited respiratory diseases including cystic fibrosis (CF),...
November 4, 2021
/PRNewswire/ -- Spirovant Sciences, a gene therapy company developing treatments and cures for inherited respiratory diseases including cystic fibrosis (CF),...
October 28, 2021
/PRNewswire/ -- Spirovant Sciences, a gene therapy company developing treatments and cures for inherited respiratory diseases including cystic fibrosis (CF),...
October 28, 2021
/PRNewswire/ -- Spirovant Sciences, a gene therapy company developing treatments and cures for inherited respiratory diseases including cystic fibrosis (CF),...
August 18, 2021
Data from the dedicated, stand-alone, ambulatory blood pressure trial will be the focus of a podium presentation Efficacy in patients with 'dry' overactive bladder, based on a post-hoc analysis
August 12, 2021
Urovant Sciences, Inc., a wholly-owned subsidiary of Sumitovant Biopharma Ltd., today announced the appointment of Betzy Estrada as executive vice president and chief human resources officer. In her
July 2, 2021
Published: Jul 02, 2021 By Alex Keown OcuTerra Therapeutics – David J. Tanzer was named Chief Medical Officer and Executive Vice President, Clinical and Medical Affairs for Boston-based OcuTerra. Prior to joining OcuTerra, Tanzer served as Global Executive Medical Director in the Novartis ophthalmology franchise. Before that, he served as the CMO at Abbott Medical Optics. He also led the Navy Refractive Surgery Program in San Diego, participating as principal or co-investigator in ove...
May 26, 2021
/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly owned subsidiary companies (Urovant, Enzyvant, Altavant and...